Institutul De Psihiatrie Socola Lasi

At Institutul De Psihiatrie Socola Lasi in Iasi, this research area focuses on treatments for schizophrenia, bipolar I disorder, and major depressive disorder, with additional work in behavioral disciplines and mental health care. The trials are designed to test new therapies, improve symptom control, and support longer-term management for people living with complex psychiatric conditions.

• Studies in schizophrenia include research on acute psychosis, inpatient care, and adolescent patients, with the goal of improving symptom relief and overall functioning.
• Trials in bipolar I disorder examine approaches for manic episodes and mixed features, aiming to reduce severity and strengthen treatment effectiveness.
• Research in major depressive disorder explores options for depressive symptoms, anhedonia, and insomnia, including efforts to prevent relapse and improve daily well-being.

Overall, the site contributes to clinical research that seeks better psychiatric treatments for both acute symptoms and longer-term outcomes.

The site also supports clinical studies linked to nervous system diseases, especially conditions where brain function and behavior are affected, such as Alzheimer’s disease and related psychotic or agitated states. These trials aim to evaluate new treatment options that may ease symptoms, improve cognition, and enhance quality of life for patients and caregivers.

• Research in Alzheimer’s disease includes studies of agitation, hallucinations, and delusions, with a focus on better symptom management.
• Some trials address cognitive impairment and global functioning, looking for ways to support thinking skills in people with mild to moderate disease.
• The research also examines behavioral symptoms that overlap with psychiatric care, reflecting the close link between brain disorders and mental health.

This work shows a strong interest in therapies that target both neurological and psychiatric symptoms in older adults.